FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Ipca Laboratories Limited)

View source ↗

Summary

The FDA approved a supplemental application for hydroxychloroquine sulfate from Ipca Laboratories Limited, approving changes to an already-approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Hydroxychloroquine sulfate (Hydroxychloroquine sulfate)

Snippet

SUPPL AP for HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULFATE)